4//SEC Filing
Pirzkall Andrea 4
Accession 0001104659-21-046732
CIK 0001737953other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 8:19 PM ET
Size
7.7 KB
Accession
0001104659-21-046732
Insider Transaction Report
Form 4
Pirzkall Andrea
Chief Medical Officer
Transactions
- Award
Common Stock
2021-04-01+20,500→ 21,500 total - Award
Employee Stock Option (right to buy)
2021-04-01+30,750→ 30,750 totalExercise: $31.58Exp: 2031-04-01→ Common Stock (30,750 underlying)
Footnotes (3)
- [F1]Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer.
- [F2]1,000 shares of the Issuer's common stock are held by the Reporting Person's husband. The Reporting Person may be deemed to be the beneficial owner of such shares.
- [F3]25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001818578
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 8:19 PM ET
- Size
- 7.7 KB